NasdaqGS - Delayed Quote USD

Exscientia plc (EXAI)

4.1300 -0.2500 (-5.71%)
At close: April 24 at 4:00 PM EDT
4.1303 +0.00 (+0.01%)
After hours: April 24 at 7:23 PM EDT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,079.0000
20,079.0000
27,223.0000
27,359.0000
9,672.0000
Cost of Revenue
27,403.0000
27,403.0000
33,297.0000
17,112.0000
14,226.0000
Gross Profit
-7,324.0000
-7,324.0000
-6,074.0000
10,247.0000
-4,554.0000
Operating Expense
167,139.0000
167,139.0000
161,539.0000
66,081.0000
15,573.0000
Operating Income
-174,463.0000
-174,463.0000
-167,613.0000
-55,834.0000
-20,127.0000
Net Non Operating Interest Income Expense
15,561.0000
15,561.0000
5,347.0000
-143.0000
21.0000
Other Income Expense
-3,186.0000
-3,186.0000
21,631.0000
-214.0000
-4,273.0000
Pretax Income
-162,088.0000
-162,088.0000
-140,635.0000
-56,191.0000
-24,379.0000
Tax Provision
-16,125.0000
-16,125.0000
-21,907.0000
-6,960.0000
-2,096.0000
Net Income Common Stockholders
-145,963.0000
-145,963.0000
-118,728.0000
-49,231.0000
-22,283.0000
Diluted NI Available to Com Stockholders
-145,963.0000
-145,963.0000
-118,728.0000
-49,231.0000
-22,283.0000
Basic EPS
-1.17
-1.18
-0.97
-0.99
-0.00
Diluted EPS
-1.17
-1.18
-0.97
-0.99
-0.00
Basic Average Shares
123,614.1860
124,197.0000
122,119.6350
49,876.0810
82,099,248.0000
Diluted Average Shares
123,614.1860
124,197.0000
122,119.6350
49,876.0810
82,099,248.0000
Total Operating Income as Reported
-176,004.0000
-176,004.0000
-145,291.0000
-54,896.0000
-23,189.0000
Total Expenses
194,542.0000
194,542.0000
194,836.0000
83,193.0000
29,799.0000
Net Income from Continuing & Discontinued Operation
-145,963.0000
-145,963.0000
-118,728.0000
-49,231.0000
-22,283.0000
Normalized Income
-144,575.3033
-144,575.3033
-137,572.8567
-50,052.8163
-19,484.2574
Interest Income
16,628.0000
16,628.0000
5,681.0000
26.0000
110.0000
Interest Expense
1,067.0000
1,067.0000
334.0000
169.0000
89.0000
Net Interest Income
15,561.0000
15,561.0000
5,347.0000
-143.0000
21.0000
EBIT
-161,021.0000
-161,021.0000
-140,301.0000
-56,022.0000
-24,290.0000
EBITDA
-145,453.0000
-145,453.0000
-130,817.0000
-51,839.0000
-23,225.0000
Reconciled Cost of Revenue
27,403.0000
27,403.0000
33,297.0000
17,112.0000
14,226.0000
Reconciled Depreciation
15,568.0000
15,568.0000
9,484.0000
4,183.0000
1,065.0000
Net Income from Continuing Operation Net Minority Interest
-145,963.0000
-145,963.0000
-118,728.0000
-49,231.0000
-22,283.0000
Total Unusual Items Excluding Goodwill
-1,541.0000
-1,541.0000
22,322.0000
938.0000
-3,062.0000
Total Unusual Items
-1,541.0000
-1,541.0000
22,322.0000
938.0000
-3,062.0000
Normalized EBITDA
-143,912.0000
-143,912.0000
-153,139.0000
-52,777.0000
-20,163.0000
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
-153.3033
-153.3033
3,477.1433
116.1837
-263.2574
12/31/2020 - 10/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABSI Absci Corporation
4.5300
-3.82%
 
RLAY Relay Therapeutics, Inc.
6.35
+7.63%
 
RXRX Recursion Pharmaceuticals, Inc.
7.94
+3.12%
 
CRBU Caribou Biosciences, Inc.
3.8500
-3.27%
 
BEAM Beam Therapeutics Inc.
22.74
-3.11%
 
BTAI BioXcel Therapeutics, Inc.
2.7100
-8.75%
 
SANA Sana Biotechnology, Inc.
8.58
+6.06%
 
PRME Prime Medicine, Inc.
4.7000
-2.08%
 
VERV Verve Therapeutics, Inc.
6.58
-4.36%
 
BAI.AS BenevolentAI S.A.
0.7300
+7.35%